World's Best Scientists 2026 revealed!
Zwi N. Berneman

Zwi N. Berneman

D-Index & Metrics

Immunology

D-Index
80
Citations
24450
World Ranking
1620
National Ranking
20

Overview

Zwi N. Berneman is affiliated with the University of Antwerp in Belgium. Their research spans multiple areas within medicine, with a focus on immunology, oncology, and hematology. The scientist has contributed extensively to the fields of immunotherapy and immune responses, cancer immunotherapy and biomarkers, CAR-T cell therapy research, and acute myeloid leukemia research.

The main fields of study of Berneman include Medicine and Immunology and Microbiology, with significant work in subfields such as Immunology, Oncology, Molecular Biology, Hematology, and Infectious Diseases. Their academic output reflects a strong interest in emerging therapeutic approaches and immune-related cancer therapies.

Recent publications highlight a focus on cancer immunotherapy and clinical oncology. Notable papers include:

  • Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma, 2020, Journal of Hematology & Oncology
  • Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3, 2024, Journal of Clinical Oncology
  • Trial watch: Dendritic cell (DC)-based immunotherapy for cancer, 2022, OncoImmunology
  • A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy, 2021, Journal of Experimental & Clinical Cancer Research
  • SARS-CoV-2 and cancer: Are they really partners in crime?, 2020, Cancer Treatment Reviews

Berneman frequently publishes in journals such as Frontiers in Immunology, Cancers, Journal of Hematology & Oncology, bioRxiv (Cold Spring Harbor Laboratory), and the European Journal of Cancer. Each of these venues features a substantial number of their papers, reflecting a consistent contribution to both immunology and oncology.

Collaboration is a significant element of their work. Frequent coauthors include Sébastien Anguille, Marc Peeters, Eva Lion, Peter A. van Dam, and Evelien Smits. These collaborations involve multiple joint publications, underscoring a networked approach to research in immunotherapy and cancer biology.

Main topics covered by Berneman's research portfolio encompass:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Renal and related cancers
  • Acute Myeloid Leukemia Research
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies

Best Publications

  • Clinical use of dendritic cells for cancer therapy

    Sébastien Anguille;Evelien L. Smits;Eva Lion;Viggo F. van Tendeloo

  • Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.

    Viggo F. I. Van Tendeloo;Peter Ponsaerts;Filip Lardon;Griet Nijs

  • Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

    Lucien Noens;Marie Anne Van Lierde;Robrecht De Bock;Gregor Verhoef

  • Cell cycle and apoptosis.

    Katrien Vermeulen;Zwi N. Berneman;Dirk R. Van Bockstaele

  • Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis.

    Jelle Praet;Caroline Guglielmetti;Zwi Berneman;Anne-Marie Van Der Linden

  • Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

    Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

  • Apoptosis: mechanisms and relevance in cancer.

    Katrien Vermeulen;Dirk R. Van Bockstaele;Zwi N. Berneman

  • Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells

    Nathalie Cools;Peter Ponsaerts;Viggo F. I. Van Tendeloo;Zwi N. Berneman

  • Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

    Thierry VandenDriessche;Lieven Thorrez;Luigi Naldini;Antonia Follenzi

  • Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)

    B. Lowenberg;S. Suciu;E. Archimbaud;G.J. Ossenkoppele

  • Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus.

    Zwi N. Berneman;Dharam V. Ablashi;Ge Li;Maureen Eger-Fletcher

  • Regulatory T cells and human disease.

    Nathalie Cools;Peter Ponsaerts;Viggo F. I. Van Tendeloo;Zwi N. Berneman

  • The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy

    Evelien L. J. M. Smits;Peter Ponsaerts;Zwi N. Berneman;Viggo F. I. Van Tendeloo

  • CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus

    Paolo Lusso;Paola Secchiero;Richard W. Crowley;Alfredo Garzino-Demo

  • Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I.

    I J Koralnik;A Gessain;M E Klotman;A Lo Monico

  • Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

    Sébastien Anguille;Ann L. Van De Velde;Evelien L. Smits;Viggo F. Van Tendeloo

  • Human herpesvirus-6 strain groups: a nomenclature

    D. Ablashi;H. Agut;Z. Berneman;G. Campadelli-Fiume

  • Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.

    Jan Jacques Michiels;Ulrich Budde;Marc van der Planken;Huub H.D.M. van Vliet

  • Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial.

    An Coosemans;Anke Vanderstraeten;Sandra Tuyaerts;Tina Verschuere

  • Cancer immunotherapy using RNA-loaded dendritic cells.

    P. Ponsaerts;V. F. I. Van Tendeloo;Z. N. Berneman

  • Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

    Sergio Amadori;Stefan Suciu;Ulrich Jehn;Roberto Stasi

Frequent Co-Authors

Viggo Van Tendeloo
Viggo Van Tendeloo University of Antwerp
Evelien Smits
Evelien Smits University of Antwerp
Herman Goossens
Herman Goossens University of Antwerp
Niel Hens
Niel Hens Hasselt University
Annemie Van der Linden
Annemie Van der Linden University of Antwerp
Patrick Cras
Patrick Cras University of Antwerp
Marc Peeters
Marc Peeters University of Antwerp
Patrick Pauwels
Patrick Pauwels University of Antwerp
Stefan Suciu
Stefan Suciu European Organisation for Research and Treatment of Cancer
Haruo Sugiyama
Haruo Sugiyama Osaka University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related online degrees offer diverse career pathways, especially in healthcare and research. Nursing programs, such as [easiest nurse practitioner degree programs](https://research.com/degrees/easiest-nurse-practitioner-degree-programs), provide a streamlined path to becoming advanced practice registered nurses with a focus on patient care.

Mental health is another vital area intersecting with immunology. Programs like the [best pmhnp programs](https://research.com/degrees/top-online-pmhnp-programs-with-best-clinical-placement-rates) specialize in psychiatric-mental health nurse practitioner training, often highlighting strong clinical placement rates that support real-world experience.

Affordability is a critical factor when selecting a program. Many students prioritize the [cheapest psychiatric nurse practitioner programs](https://research.com/degrees/most-affordable-online-psychiatric-nurse-practitioner-programs) to minimize financial burden while obtaining quality education. Such programs balance cost with essential hands-on training.

Career prospects for graduates vary, with salaries influenced by factors including location and specialization. Understanding [how much do dnp nurses make](https://research.com/careers/average-dnp-salary-by-state) helps students make informed decisions about their educational investments and potential returns in the nursing field.

Best Scientists Citing Zwi N. Berneman

Trending Scientists